HWM
Holloway Wealth Management Portfolio holdings
AUM
$350M
This Quarter Return
-2.07%
1 Year Return
+10.16%
3 Year Return
+50.68%
5 Year Return
+63.44%
10 Year Return
–
AUM
$184M
AUM Growth
+$184M
(+1.8%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
39.15%
Holding
342
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 18.42% |
| 2 | Technology | 15.02% |
| 3 | Energy | 14.16% |
| 4 | Consumer Discretionary | 8.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDS.B
1
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| – | – | 0 | – | – |
|
2
Apple
AAPL
$3.45T
| – | – | 0 | – | – |
|
3
AT&T
T
$209B
| – | – | 0 | – | – |
|
4
Bank of America
BAC
$376B
| – | – | 0 | – | – |
|
5
Citigroup
C
$178B
| – | – | 0 | – | – |
|
6
Cisco
CSCO
$274B
| – | – | 0 | – | – |
|
|
CIM
7
Chimera Investment
CIM
$1.15B
| – | – | 0 | – | – |
|
8
Intel
INTC
$107B
| – | – | 0 | – | – |
|
9
Macy's
M
$3.59B
| – | – | 0 | – | – |
|
10
Kinder Morgan
KMI
$60B
| – | – | 0 | – | – |
|
11
Gilead Sciences
GILD
$140B
| – | – | 0 | – | – |
|
12
GSK
GSK
$79.9B
| – | – | 0 | – | – |
|
13
Altria Group
MO
$113B
| – | – | 0 | – | – |
|
14
Occidental Petroleum
OXY
$46.9B
| – | – | 0 | – | – |
|
15
Chevron
CVX
$324B
| – | – | 0 | – | – |
|
16
Bristol-Myers Squibb
BMY
$96B
| – | – | 0 | – | – |
|
17
Walmart
WMT
$774B
| – | – | 0 | – | – |
|
18
Pfizer
PFE
$141B
| – | – | 0 | – | – |
|
19
General Motors
GM
$55.8B
| – | – | 0 | – | – |
|
20
Royal Caribbean
RCL
$98.7B
| – | – | 0 | – | – |
|
21
Northrop Grumman
NOC
$84.5B
| – | – | 0 | – | – |
|
22
IBM
IBM
$227B
| – | – | 0 | – | – |
|
23
Amgen
AMGN
$155B
| – | – | 0 | – | – |
|
24
Medtronic
MDT
$119B
| – | – | 0 | – | – |
|
25
Novartis
NVS
$245B
| – | – | 0 | – | – |
|